Cargando…
With Chitosan and PLGA as the Delivery Vehicle, Toxoplasma gondii Oxidoreductase-Based DNA Vaccines Decrease Parasite Burdens in Mice
Toxoplasma gondii (T. gondii) is an intracellular parasitic protozoan that can cause serious public health problems. However, there is no effectively preventive or therapeutic strategy available for human and animals. In the present study, we developed a DNA vaccine encoding T. gondii oxidoreductase...
Autores principales: | Yu, Zhengqing, Cao, Wandi, Gao, Xuchen, Aleem, Muhammad Tahir, Liu, Junlong, Luo, Jianxun, Yan, Ruofeng, Xu, Lixin, Song, Xiaokai, Li, Xiangrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430031/ https://www.ncbi.nlm.nih.gov/pubmed/34512659 http://dx.doi.org/10.3389/fimmu.2021.726615 |
Ejemplares similares
-
Toxoplasma gondii Proteasome Subunit Alpha Type 1 with Chitosan: A Promising Alternative to Traditional Adjuvant
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Nano DNA Vaccine Encoding Toxoplasma gondii Histone Deacetylase SIR2 Enhanced Protective Immunity in Mice
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Recombinant Toxoplasma gondii Ribosomal Protein P2 Modulates the Functions of Murine Macrophages In Vitro and Provides Immunity against Acute Toxoplasmosis In Vivo
por: Yu, Zhengqing, et al.
Publicado: (2021) -
Modulation Effects of Toxoplasma gondii Histone H2A1 on Murine Macrophages and Encapsulation with Polymer as a Vaccine Candidate
por: Yu, Zhengqing, et al.
Publicado: (2020) -
Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis
por: Yu, ZhengQing, et al.
Publicado: (2022)